Genotyping and population structure of the China Kadoorie Biobank
Walters RGPapers in this archive, Millwood IYPapers in this archive, Lin KPapers in this archive, Valle DSPapers in this archive, McDonnell PPapers in this archive, Hacker APapers in this archive, Avery DPapers in this archive, Cai NPapers in this archive, Kretzschmar WWPapers in this archive, Ansari MAPapers in this archive, Lyons PAPapers in this archive, Collins RPapers in this archive, Donnelly PPapers in this archive, Hill MPapers in this archive, Peto RPapers in this archive, Shen HPapers in this archive, Jin XPapers in this archive, Nie CPapers in this archive, Xu XPapers in this archive, Guo YPapers in this archive, Yu CPapers in this archive, Lv JPapers in this archive, Clarke RJPapers in this archive, Li LPapers in this archive, Chen ZPapers in this archive, the China Kadoorie Biobank Collaborative Group
Abstract
China Kadoorie Biobank is a population-based prospective cohort of >512,000 adults recruited in 2004-2008 from 10 geographically diverse regions across China. Detailed data from questionnaire and physical measurements were collected at baseline, with additional measurements at three resurveys involving approximately 5% of surviving participants. Incident disease events are captured through electronic linkage to death and disease registries and to the national health insurance system. Genome-wide genotyping has been conducted for >100,000 participants using custom-designed Axiom® arrays. Analysis of these data reveals extensive relatedness within the CKB cohort, signatures of recent consanguinity, and principal component signatures reflecting large-scale population movements from recent Chinese history. In addition to numerous CKB studies of candidate drug targets and disease risk factors, CKB has made substantial contributions to many international genetics consortia. Collected biosamples are now being used for high-throughput 'omics assays which, together with planned whole genome sequencing, will continue to enhance the scientific value of this biobank. medRxiv preprint doi: https://doi.org/10.1101/2022.05.02.22274487; this version posted May 3, 2022. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license .
This page indexes the study's public bibliographic record. The full text belongs to the journal; follow the DOI above to read it at the source.